Challenging issues pertaining protection of the patent regarding human genetics unit for disease treatment

Main Article Content

ปวีณ นราเมธกุล
วริยา ล้ำเลิศ
มานา นราเมธกุล


Patent is an intellectual property which is an industrial property classified as a scientific invention that is valuable towards the economy. To ensure that the value of thought or research and invention is not imitated, the state has planned a suitable lawful system to enforce protection. This has benefitted the advancement of science, engineering and businesses that aims to increase the marketing value of products. In return, confidence is formed with the consumer, thus, creating more opportunities to receive funding, improving industrial resources.

        According to a study of the principles, concepts, and theories underlying patent protection for human genes used for therapeutic purposes, as well as a comparative analysis of international agreements, foreign and Thai laws governing patent applications for human genes used for therapeutic purposes, it was determined that there is no definition of human genes in patent law. This could raise concerns about the clarity with which government agencies responsible for patent applications involving human genetics for the treatment of diseases and the justice system interpret patent applications involving human genetics for the medical purposes. The composition of the patent application for therapeutic human genes is critical for the patent application system to protect therapeutic human genomes. If the composition of a patent on a human gene for therapeutic purposes is clearly defined, the problem of specifying the scope of claims that are too broad can be resolved.

Thus, the author agreed that the law should be amended to grant the patenting of human genes for therapeutic purposes in Thailand. It is proposed to amend section 9 of the Patent Act B.E. 2522 by adding the definition of scientific terminology Reduce the problem of interpreting the scope of the word definition. “Genetic material” and “derivative” amend the content of the provisions of Section 9 to protect genetic material, derivative, extract or any other thing or any part One of the creatures created by humans for the purpose of disease treatment and increase the protection of intellectual property by clearly stipulating in the constitution by requiring the State to provide and promote research, innovation, invention or discovery to create new knowledge. by focusing on biotechnology for the prevention and disease treatment.

Article Details

How to Cite
นราเมธกุล ป., ล้ำเลิศ ว. ., & นราเมธกุล ม. . (2022). Challenging issues pertaining protection of the patent regarding human genetics unit for disease treatment. Rattanakosin Journal of Science and Technology, 4(1), 13–21. Retrieved from
Research Articles


MedlinePlus. What is a Gene .


MedlinePlus. What are genome editing an CRISPR Cas9.

Lumen. Mendel’s Law of Heredity.

Biological Principles. Chromosome theory of inheritance.

รองศาสตราจารย ดร. สมชาย กษิติประดิษฐ, “สิทธิมนุษยชน Human Rights (LW 446)” (กรุงเทพฯ : สำนักพิมพมหาวิทยาลัยรามคําแหง) หน้า 5–22

Council for International Organizations of Medical Sciences (CIOMS), International Ethical Guidelines for biomedical research involving human subjects. articles/PMC1376447/pdf/jmedeth00291-0061.pdf

Declaration of Helsinki 2008.

Good Clinical Practice Network, Institutional Review Board/Independent Ethics Committee (IRB/IEC).

สำนักงานคณะกรรมการกฤษฎีกา. พระราชบัญญัติสิทธิบัตร พ.ศ. 2522 .

ราชกิจจานุเบกษา.รัฐธรรมนูญแห่งราชอาณาจักรไทย พ.ศ. 2560.

Convention on Biological Diversity.

กรมทรัพย์สินทางปัญญา. ร่างพระราชบัญญัติสิทธิบัตร (ฉบับที่ ..) พ.ศ. ....